Latest News
Here you can find all the latest news from the UCL Innovative Clinical Trials Unit (formerly the MRC CTU at UCL).
Global NeoSep1 trial expands to India to tackle neonatal sepsis
The first infant has been enrolled in India as NeoSep1 extends recruitment across the Asia-Pacific region to evaluate antibiotic treatments for neonatal sepsis.
New podcast episode: The ACORD Collaboration: Innovative Clinical Trials for Neurodegenerative Diseases
In this Trial Talk episode, we speak to James Carpenter and Ed Jabbari about the ACORD collaboration and its potential to change the landscape of clinical research in neurodegenerative diseases.
SNAP trial shows safer antibiotic option for staph blood infection
Cefazolin is a better option than flucloxacillin to treat strap blood infections. Also, penicillin can be used instead of flucloxacillin iIn some cases.
Using two immunotherapy drugs together benefits people with kidney cancer
New results from the RAMPART trial found that giving durvalumab alone did not help prevent kidney cancer from coming back after surgery compared to active monitoring.
A new trial for people living with relapsing-remitting multiple sclerosis launches in the UK
The REFINE-MS trial will evaluate if people living with relapsing-remitting MS can take treatment less often while keeping their disease activity under control.